Vignesh Rajah, SVP and CMO at Y-mAbs Therapeutics, Inc. (YMAB), bought 3,161 shares at $45.74 ($146K) on 2020-11-17, disclosed to the SEC on 2020-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.74 | 1,464 | $67K | 45.9% |
| 2 | $45.74 | 1,464 | $67K | 45.9% |
| 3 | $51.03 | 233 | $12K | 8.2% |
| Total | $46.13 avg | 3,161 | $146K | 100% |
| Filing → |
| YMAB | BUY | 2021-08-13 | $41K | — | Filing → |